Inteins catalyze protein splicing in a fashion similar to how self-splicing introns catalyze RNA splicing. Split-inteins catalyze precise ligation of two separate polypeptides through trans-splicing in a highly specific manner. Here we report a method of using protein trans-splicing to circumvent the packaging size limit of gene therapy vectors. To demonstrate this method, we chose a large dystrophin gene and an adeno-associated viral (AAV) vector, which has a small packaging size. A highly functional 6.3-kb Becker-form dystrophin cDNA was broken into two pieces and modified by adding appropriate split-intein coding sequences, resulting in split-genes sufficiently small for packaging in AAV vectors. The two split-genes, after codelivery into target cells, produced two polypeptides that spontaneously trans-spliced to form the expected Becker-form dystrophin protein in cell culture in vitro. Delivering the split-genes by AAV1 vectors into the muscle of a mouse model of Duchenne muscular dystrophy rendered therapeutic gene expression and benefits.
Get full access to this article
View all access options for this article.
References
1.
ChaoH., SunL., BruceA., XiaoX., WalshC.E.2002. Expression of human factor VIII by splicing between dimerized AAV vectors. Mol. Ther., 5:716–722.
2.
ChenL., ZhuF., LiJ., LuH., JiangH., SarkarR., ArrudaV.R., WangJ., ZhaoJ., PierceG.F., DingQ., WangX., WangH., PipeS.W., LiuX.Q., XiaoX., CamireR.M., XiaoW.2007. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol. Ther., 15:1856–1862.
3.
DuanD., YueY., YanZ., EngelhardtJ.F.2000. A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat. Med., 6:595–598.
4.
DuanD., YueY., EngelhardtJ.F.2001. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison. Mol. Ther., 4:383–391.
5.
EnglandS.B., NicholsonL.V., JohnsonM.A., ForrestS.M., LoveD.R., Zubrzycka-GaarnE.E., BulmanD.E., HarrisJ.B., DaviesK.E.1990. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature, 343:180–182.
FlotteT.R., AfioneS.A., SolowR., DrummM.L., MarkakisD., GugginoW.B., ZeitlinP.L., CarterB.J.1993. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem., 268:3781–3790.
8.
HarperS.Q., HauserM.A., DellorussoC., DuanD., CrawfordR.W., PhelpsS.F., HarperH.A., RobinsonA.S., EngelhardtJ.F., BrooksS.V., ChamberlainJ.S.2002. Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy. Nat. Med., 8:253–261.
9.
Hartigan-O'ConnorD., ChamberlainJ.S.2000. Developments in gene therapy for muscular dystrophy. Microsc. Res. Tech., 48:223–238.
10.
KoenigM., KunkelL.M.1990. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem., 265:4560–4566.
11.
KoenigM., HoffmanE.P., BertelsonC.J., MonacoA.P., FeenerC., KunkelL.M.1987. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell, 50:509–517.
12.
LiJ., DressmanD., TsaoY.P., SakamotoA., HoffmanE.P., XiaoX.1999. rAAV vector-mediated sarcoglycan gene transfer in a hamster model for limb girdle muscular dystrophy. Gene Ther., 6:74–82.
13.
LiuX.Q., HuZ.1997. A DnaB intein in Rhodothermus marinus: Indication of recent intein homing across remotely related organisms. Proc. Natl. Acad. Sci. U.S.A., 94:7851–7856.
14.
MahC., SarkarR., ZolotukhinI., SchleissingM., XiaoX., KazazianH.H., ByrneB.J.2003. Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice. Hum. Gene Ther., 14:143–152.
15.
NakaiH., StormT.A., KayM.A.2000. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol., 18:527–532.
16.
PhelpsS.F., HauserM.A., ColeN.M., RafaelJ.A., HinkleR.T., FaulknerJ.A., ChamberlainJ.S.1995. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum. Mol. Genet, 4:1251–1258.
17.
QiaoC., LiJ., ZhuT., DraviamR., WatkinsS., YeX., ChenC., LiJ., XiaoX.2005. Amelioration of laminin-α2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin. Proc. Natl. Acad. Sci. U.S.A., 102:11999–12004.
18.
SarkarR., XiaoW., KazazianH.H.Jr.2003. A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype. J. Thromb. Haemost., 1:220–226.
19.
SnyderR.O., XiaoX., SamulskiR.1996. Production of recombinant adeno-associated viral vectors. Current Protocols in Human Genetics. DracopoliN., HainesJ., KrofB., MoirD., SeidmanC., SeidmanJ., SmithD.John Wiley & Sons: New York, 12.11.11–12.12.23.
20.
SnyderR.O., SprattS.K., LagardeC., BohlD., KasparB., SloanB., CohenL.K., DanosO.1997. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther., 8:1891–1900.
21.
SunL., LiJ., XiaoX.2000. Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med., 6:599–602.
22.
WangB., LiJ., XiaoX.2000. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. U.S.A., 97:13714–13719.
WuH., HuZ., LiuX.Q.1998a. Protein trans-splicing by a split intein encoded in a split DnaE gene of Synechocystis sp. PCC6803. Proc. Natl. Acad. Sci. U.S.A., 959226–9231.
25.
WuH., XuM.Q., LiuX.Q.1998b. Protein trans-splicing and functional mini-inteins of a cyanobacterial dnaB intein. Biochim. Biophys. Acta, 1387:422–432.
26.
XiaoX., LiJ., SamulskiR.J.1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol., 70:8098–8108.
27.
XiaoX., LiJ., TsaoY.P., DressmanD., HoffmanE.P., WatchkoJ.F.2000. Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy. J. Virol., 74:1436–1442.
28.
YanZ., ZhangY., DuanD., EngelhardtJ.F.2000. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl. Acad. Sci. U.S.A., 97:6716–6721.
29.
ZhangL., WangD., FischerH., FanP.D., WiddicombeJ.H., KanY.W., DongJ.Y.1998. Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc. Natl. Acad. Sci. U.S.A., 95:10158–10163.
